DrugPatentWatch Database Preview
Actavis Labs Fl Inc Company Profile
» See Plans and Pricing
What is the competitive landscape for ACTAVIS LABS FL INC, and what generic and branded alternatives to ACTAVIS LABS FL INC drugs are available?
ACTAVIS LABS FL INC has sixty-two approved drugs.
There are four tentative approvals on ACTAVIS LABS FL INC drugs.
Summary for Actavis Labs Fl Inc
| US Patents: | 0 |
| Tradenames: | 51 |
| Ingredients: | 49 |
| NDAs: | 62 |
Drugs and US Patents for Actavis Labs Fl Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Actavis Labs Fl Inc | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 203693-002 | Oct 16, 2017 | DISCN | No | No | Start Trial | Start Trial | |||||
| Actavis Labs Fl Inc | FENTANYL CITRATE | fentanyl citrate | TABLET;SUBLINGUAL | 207338-006 | Nov 17, 2017 | DISCN | No | No | Start Trial | Start Trial | |||||
| Actavis Labs Fl Inc | METFORMIN HYDROCHLORIDE | metformin hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 076869-001 | Apr 12, 2005 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Actavis Labs Fl Inc | ZOLPIDEM TARTRATE | zolpidem tartrate | TABLET, EXTENDED RELEASE;ORAL | 090153-002 | Mar 25, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Paragraph IV (Patent) Challenges for ACTAVIS LABS FL INC drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
